Aurintricarboxylic acid (ATA) was found to be a very potent inhibitor of purified rabbit liver phosphofructokinase (PFK), giving 50 % inhibition at 0.2,/M. The inhibition was in a manner consistent with interaction at the citrate-inhibitory site of the enzyme. The data suggest that inhibition of PFK by ATA was not due to denaturation of the enzyme or the irreversible binding of inhibitor, since the inhibition could be reversed by addition of allosteric activators of PFK, i.e. fructose 2,6-bisphosphate or AMP. Two other tricarboxylic acids, agaric acid and (-)-hydroxycitrate, were found to inhibit PFK. ATA at much higher concentrations (500 /M) was shown to inhibit fatty acid synthesis from endogenous glycogen in rat hepatocytes; however, protein synthesis was not altered. 
INTRODUCTION
Aurintricarboxylic acid (ATA) has been used extensively as an inhibitor of protein synthesis in cell-free systems [1, 2] and more recently to stimulate transcription and translation in mitochondrial lysates [3] ; however, the effect of ATA on other enzymes has not been reported. Phosphofructokinase (PFK) activity has been observed to be inhibited by polycarboxylic aromatic compounds as well as by various citrate analogues [4] . Since ATA is a carboxylic acid, it was possible that ATA might also inhibit PFK. In the present study the effect of ATA on purified PFK has been examined.
Previous studies with isolated hepatocytes in this laboratory have demonstrated that some other carboxylic acids inhibit lipogenesis [5] [6] [7] ; therefore a preliminary study on ATA's effect on lipogenesis and protein synthesis is reported.
MATERIALS AND METHODS
Enzyme purification and assays PFK was purified from rabbit liver as described by Kemp [8] , with minor modifications. In the modified procedure, the (NH4)2SO4 cut was replaced by precipitation with 600 (w/v) polyethylene glycol 6000, the ion-exchange step was performed with DEAE-Sephadex A-25, and the gel filtration was performed on Sephacryl S-300. The enzyme was over 9000 homogeneous by polyacrylamide-gel electrophoresis. PFK was assayed as described previously [9] , except that the pH was 7.3. Glycerol-phosphate dehydrogenase was assayed in 50 mM-Tes/NaOH, pH 7.3, containing 150 mM-KCl, 1 [12] with minor modifications [13] [13] . The rate of protein synthesis was determined by incorporation of [3H]leucine as described previously [14] . Materials ATA, agaric acid and all biochemical reagents were purchased from Sigma Chemical Co., St 
RESULTS AND DISCUSSION
It was found that ATA is a potent inhibitor of liver PFK in vitro. As shown in Fig. 1 , PFK was inhibited by 500 by 0.2 ,tM-ATA at pH 7.3 under the conditions used. The enzyme was virtually unaffected by 2.0,UM-ATA when assayed at pH 8, where PFK does not exhibit allosteric behaviour. As shown in Fig. 2 , ATA increased both the so 5 for fructose 6-phosphate and the sensitivity to ATP inhibition. Fructose 2,6-bisphosphate counteracted this inhibition (Fig. 2) . In a separate experiment (Table 1 ), the data suggest that inhibition of PFK by ATA was not due to denaturation of the enzyme or the irreversible binding of inhibitor. Not only did inhibition tend to be reversed by addition of allosteric activators of PFK, but PFK could be incubated with up to 1O /M- ATA for 30 min with no loss of activity at pH 8 (results not shown). However, ATA proved at higher concentrations to be a general enzyme inhibitor. For example, the auxiliary enzymes of the PFK assay (aldolase and glycerol-phosphate dehydrogenase from rabbit muscle) were sensitive to higher concentrations of ATA, being inhibited by 5000 by about 3 fLM-ATA. The PFK assays were not affected, however, since these were performed at ATA concentrations no higher than 1 /tM and in the presence of an excess of auxiliary-enzyme activity. Other enzymes also were inhibited by much higher concentrations of ATA. Pyruvate kinase and lactate dehydrogenase from rabbit muscle were inhibited by 5000 by 50 /iM-and 20 ,M-ATA respectively. Rat liver fructose-1,6-bisphosphatase (supplied by Dr. Frank Marcus of Chicago Medical School) was inhibited by 5000 by about 10 ,#M-ATA. ATP-citrate lyase was inhibited by 3700 at 50 ,M-ATA (assayed by Dr. K. Roehrig of Ohio State University).
Although we calculated the concentration of ATA on the basis of the Mr of its nominal tris(salicylyl)methane structure, Gonzalez et al. [15] reported that ATA existed as a heterogeneous collection of polymers of this basic structure; those authors partially fractionated these polymers by dialysis and ultrafiltration. We accomplished a similar fractionation of ATA by passage over Sephadex G-50 equilibrated with 10 mM-NH3. ATA fractions eluted in the void volume inhibited PFK to the same extent on a weight basis as did fractions eluted in the salt volume after freeze-drying and reconstitution in water. Therefore it appeared that all polymeric forms of ATA were equally effective on a weight basis in inhibiting PFK. In addition, ATA could be desalted by passage over Sephadex G-15 equilibrated with 10 mM-NH3; the G-15-treated ATA inhibited PFK equally as well as did unfractionated ATA, indicating that low-Mr impurities were not responsible for the inhibition.
Given that ATA is an allosteric inhibitor of PFK, the question of its exact site of action arises. We speculate that ATA may interact with the citrate-binding site on PFK, since inhibition of PFK by ATA is qualitatively similar to inhibition of PFK by citrate. Also, the citratebinding site on PFK is known to be relatively non- [18, 19] . This may be a common problem with tricarboxylic acids in hepatocytes.
Two other tricarboxylic acid which decrease fatty acid synthesis in hepatocytes, agaric acid [18] and (-)-hydroxycitrate [19] , were also tested to see if they inhibit PFK. In our assay system PFK was inhibited by 730 by 10 /tM-agaric acid, 500 by 1 mM-( -)-hydroxycitrate and 5000 by 1 2 March 1989 time [16] . This might be explained by inhibition of PFK in the cell. These findings might be due to a change in redox state because of repression of glycolysis. Another explanation might be that one of the many other sites of inhibition proposed for agaric acid (citrate transport, adenine nucleotide transport and the enzyme aconitase [18] ) might cause these effects on lactate. With the current studies we have not ruled the possibility that ATA at higher concentrations or with longer periods of incubation might be inhibiting other enzymes or transporters in the cells.
